Genome-Wide Analysis Identifies Nuclear Factor 1C as a Novel Transcription Factor and Potential Therapeutic Target in SCLC
Vivek Shukla(National Institutes of Health), David S. Schrump(National Institutes of Health), Xinwei Wu(Qilu Hospital of Shandong University), Stephanie Shiffka(National Cancer Institute), Gordon L. Hager(National Institutes of Health), Mary R. Zhang(National Cancer Institute), Frank Echtenkamp(National Cancer Institute), Lyuba Varticovski(National Cancer Institute), Songjoon Baek(National Institutes of Health), Ruihong Wang(National Cancer Institute), W. Marston Linehan(Harvard University), Haobin Chen(Washington University in St. Louis), Razi Raziuddin(National Institutes of Health), Frank Villa-Hernandez(National Cancer Institute), Leonard Μ. Neckers(National Cancer Institute), Katherine P. Prothro(National Cancer Institute), Haitao Wang(National Cancer Institute), Sudheer Kumar Gara(National Cancer Center)
Cited by 8
Related Papers
Brca1 breast tumors contain distinct CD44+/CD24- and CD133+cells with cancer stem cell characteristics
|Breast Cancer Research|2008|660
Transcription Factor AP1 Potentiates Chromatin Accessibility and Glucocorticoid Receptor Binding
|Molecular Cell|2011|499
Adenovirus-Mediated p53 Gene Transfer in Advanced Non-Small-Cell Lung Cancer
|JNCI Journal of the National Cancer Institute|1999|497
Database Resources of the National Genomics Data Center, China National Center for Bioinformation in 2025
|Nucleic Acids Research|2024|362
Vitamins C and E and Beta Carotene Supplementation and Cancer Risk: A Randomized Controlled Trial
|JNCI Journal of the National Cancer Institute|2008|311